Neutrophil-lymphocyte ratio and Platelet to lymphocyte ratio as markers for predicting the severity in COVID-19 patients: A Prospective Observational study.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- To evaluate the ability of the NLR and PLR to predict severity in COVID-19 patients.
研究概览
简要总结
Of note, a high incidence of lymphopenia in COVID-19 patients has been seen. In addition, the baseline neutrophil-to-lymphocyte ratio (NLR) has been confirmed as a potential prognostic indicator for patients in various other studies. So identifying severe patients in the early stage is of great significance for reducing the clinical morbidity and improving the cure rate. So, we aimed to compare peripheral blood neutrophil to lymphocyte count ratio (NLR) and platelet to lymphocyte ratio to explore the clinical indicator that can predict severity of COVID-19 in the early stage.
Patients clinical symptoms and signs will be obtained from electronic medical records or files when the patient is admitted and receiving the treatment. All the relevant routine laboratory investigations will be noted from the electronic data records at the time of receiving the treatment. If required follow-up on telephone consultation will be done on the discharge.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •Only confirmed cases of COVID-19 diagnosed on the basis of ICMR standard.
排除标准
- •1.Age below 6 years.
- •2.Pregnant patients 3.Dialysis dependent patients 4.All trauma patients 5.Any malignancy 6.Any psychiatric illness 7.Consent not given.
结局指标
主要结局
To evaluate the ability of the NLR and PLR to predict severity in COVID-19 patients.
时间窗: Baseline-on admission
次要结局
- 1. Mortality(2. Length of hospitalization)